Kong Chen

Dr. Kong Chen


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
WEWaleed Elsegeiny
Waleed Elsegeiny
MZMingquan Zheng
Mingquan Zheng
TETaylor Eddens
Taylor Eddens
RGRichard L. Gallo
Richard L. Gallo
GDGuixiang Dai
Guixiang Dai
JKJay Kolls
Jay Kolls
Despite the discovery of key pattern recognition receptors and CD4 + T cell subsets in laboratory mice, there is ongoing discussion of the value of murine models to reflect human disease. Pneumocystis is an AIDS-defining illness, in which risk of infection is inversely correlated with peripheral CD4 + T cell counts. Due to medical advances in the control of HIV, the current epidemiology of Pneumocystis infection is predominantly due to primary human immunodeficiencies and immunosuppressive therapies. To this end, we found that every human genetic immunodeficiency associated with Pneumocystis infection that has been tested in mice recapitulated susceptibility. For example, humans with a loss-of-function IL21R mutation are severely immunocompromised. We found that IL-21R, in addition to CD4 + T cell intrinsic STAT3 signaling, were required for generating protective antifungal class-switched antibody responses, as well as effector T cell–mediated protection. Furthermore, CD4 + T cell intrinsic IL-21R/STAT3 signaling was required for CD4 + T cell effector responses, including IL-22 production. Recombinant IL-22 administration to Il21r –/– mice induced the expression of a fungicidal peptide, cathelicidin antimicrobial peptide, which showed in vitro fungicidal activity. In conclusion, SPF laboratory mice faithfully replicate many aspects of human primary immunodeficiency and provide useful tools to understand the generation and nature of effector CD4 + T cell immunity.

9 February 2016 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
ZYZihe Yan
Zihe Yan
JYJunjun Yang
Junjun Yang
RHRenjing Hu
Renjing Hu
XHXichi Hu
Xichi Hu
KCKong Chen
Kong Chen
Acinetobacter baumanniiis a significant cause of severe hospital-acquired infections with a recent rise in multidrug-resistant infections involving traumatic wounds of military personnel. The interleukin-17 (IL-17) pathway is essential for neutrophil recruitment in response to a variety of pathogens, while the control ofA. baumanniiinfection is known to be dependent on neutrophils. This suggests that IL-17 may play an important role inA. baumanniiinfection; however, this has yet to be studied. Here, we summarize the recent advances in understanding the host-pathogen interaction ofA. baumanniiand propose a potential role of the IL-17 pathway in generating a protective immune response.

21 July 2016 in JCI Insight
Verified
Journal Article
Open access
PDF file
KCKong Chen
Kong Chen
BCBrian T. Campfield
Brian T. Campfield
SWSally E. Wenzel
Sally E. Wenzel
JMJeremy P. McAleer
Jeremy P. McAleer
JKJames L. Kreindler
James L. Kreindler
JKJay Kolls
Jay Kolls
Significant morbidity in cystic fibrosis (CF) results from chronic lung inflammation, most commonly due to Pseudomonas aeruginosa infection. Recent data suggest that IL-17 contributes to pathological inflammation in the setting of abnormal mucosal immunity, and type 17 immunity–driven inflammatory responses may represent a target to block aberrant inflammation in CF. Indeed, transcriptomic analysis of the airway epithelium from CF patients undergoing clinical bronchoscopy revealed upregulation of IL-17 downstream signature genes, implicating a substantial contribution of IL-17–mediated immunity in CF lungs. Bromodomain and extraterminal domain (BET) chromatin modulators can regulate T cell responses, specifically Th17-mediated inflammation, by mechanisms that include bromodomain-dependent inhibition of acetylated histones at the IL17 locus. Here, we show that, in vitro , BET inhibition potently suppressed Th17 cell responses in explanted CF tissue and inhibited IL-17–driven chemokine production in human bronchial epithelial cells. In an acute P . aeruginosa lung infection murine model, BET inhibition decreased inflammation, without exacerbating infection, suggesting that BET inhibition may be a potential therapeutic target in patients with CF.

7 January 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
KMKaveh Moghbeli
Kaveh Moghbeli
MLMadeline A. Lipp
Madeline A. Lipp
Marta BuenoMarta Bueno
Marta Bueno
ACAndrew Craig
Andrew Craig
MRMichelle Rojas
Michelle Rojas
MSMark E. Snyder
Mark E. Snyder
Chronic lung allograft dysfunction (CLAD) substantially limits long-term survival following lung transplantation. To identify potential targets for CLAD prevention, T cells from explanted CLAD lungs and lung-draining lymph nodes, as well as diseased and nondiseased controls were isolated and single-cell RNA sequencing and TCR sequencing were performed. TCR sequencing revealed a clonally expanded population of CD8 + tissue-resident memory T cells (TRMs) with high cytotoxic potential, including upregulation of KLRK1 , encoding the co-receptor NKG2D. These cytotoxic CD8 + TRMs accumulated around the CLAD airways and had a 100-fold increase in clonal overlap with lung-draining lymph nodes when compared with non-CLAD lungs. Using a murine model of orthotopic lung transplantation, we confirmed that cytotoxic CD8 + TRM accumulation was due to chronic rejection and not transplantation alone. Furthermore, blocking NKG2D in vivo attenuated the airway remodeling following transplantation and diminished airway accumulation of CD8 + T cells. Our findings support NKG2D as a potential therapeutic target for CLAD, affecting cytotoxic CD8 + TRM accumulation.

21 April 2016 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
GWGuansong Wang
Guansong Wang
MBMusheng Bao
Musheng Bao
XZXiang Zhang
Xiang Zhang
Juraj MajtanJuraj Majtan
Juraj Majtan
KCKong Chen
Kong Chen

2 June 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
SCSiheng Chao
Siheng Chao
NINaoki Iwanaga
Naoki Iwanaga
HPHernan Felipe Peñaloza
Hernan Felipe Peñaloza
NLNicola Ivan Lorè
Nicola Ivan Lorè
KCKong Chen
Kong Chen
Infectious; IRCCS Ospedale San Raffaele, Milan, Italy.Barrier tissues separate the external environment from the internal environment of the human body. These specialized structures serve not only as passive physical barriers but also as dynamic regulators of molecular and cellular traffic, thereby playing a critical role in maintaining physiological homeostasis. Barrier integrity is essential across multiple systems, including the respiratory, urinary, gastrointestinal, and sensory systems. In pathological states, disruption of barrier function permits the translocation of inappropriate or excessive molecular species, which can precipitate aberrant immune activation, often skewed toward pro-inflammatory responses. Such immune dysregulation may exacerbate existing pathology or contribute to the onset of comorbid conditions.This research topic sheds light on the pathophysiology of barrier tissues is disease contexts across multiple organ systems. It emphasizes the underlying mechanisms of barrier tissue dysfunction and the immune system's role in these processes, while highlighting potential biological models and outlining future clinical research directions to manage diseases with barrier tissues in mind.The mini review by Simalee et al. describes the pathogenic roles and effects of inflammatory eosinophils (iEOS) and tissue resident eosinophils (rEOS) in Chronic rhinosinusitis with nasal polyps (CRSwNP). Simalee et al. discussed different populations of eosinophils and how an imbalance of iEOS and rEOS exacerbates the type 2 endotype of CRSwNP, both due to eosinophil mechanisms and by signaling to other immune cells. The authors also placed a heavy focus on the potential impact of CRSwNP treatments which further exploration of eosinophil population may offer; this includes anti-eosinophilia drug treatment or combinations and using subtypes of eosinophils as biomarkers in clinical disease management and as predictor variables in models.In their perspective article, Jin et al. explore the role of circulating immune complexes in the development of arthritis among patients with inflammatory bowel disease (IBD).They highlight how increased intestinal permeability, or "leaky gut", in IBD allows microbial products to enter the circulation. This translocation facilitates the formation and systemic distribution of immune complexes, which may deposit in joints and trigger inflammatory responses. The authors further discuss potential strategies to restore gut barrier integrity, emphasizing the therapeutic potential of butyrate, a short-chain fatty acid known to support epithelial health and reduce permeability. This work underscores the gut-joint axis as a possible target for preventing extraintestinal complications of IBD.The PrEP-treated and control groups, suggesting that oral PrEP does not compromise the mucosal epithelial barrier. Additionally, while TJ genes correlated with cytokine signaling, PrEP had no significant impact on inflammatory gene expression. These findings support the safety of oral PrEP in preserving epithelial integrity and encourage further investigation into its broader biological effects.In conclusion, this research topic highlights recent advancements in the study of barrier tissues across multiple organ systems. This topic presents clinically relevant discussions and insights into how dysfunctional barrier tissues may participate with health disorders. This topic aims to encourage further studies on barrier tissues and translational research, showcasing innovative models for studying barrier function, progress in biomarker discovery, and the development of novel diagnostic and treatment strategies.